The global pharmaceutical industry experienced a 30% drop in new job postings related to cloud in Q3 2023 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to a 35% decrease versus Q3 2022. GlobalData’s Pharma: Hiring Trends & Signals Q3 2023 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Computer and Mathematical Occupations jobs accounted for a 42% share of the global pharmaceutical industry’s cloud-related total new job postings in Q3 2023, down 33% over the prior quarter.
Computer and Mathematical Occupations drive cloud-related hiring activity
Computer and Mathematical Occupations, with a share of 42%, emerged as the top cloud-related job roles within the pharmaceutical industry in Q3 2023, with new job postings drop by 33% quarter-on-quarter. Management Occupations came in second with a share of 20% in Q3 2023, with new job postings dropping by 40% over the previous quarter.
See Also:
The other prominent cloud roles include Life, Physical, and Social Science Occupations with a 4% share in Q3 2023, Architecture and Engineering Occupations with a 4% share of new job postings.
Top five companies in pharmaceutical industry accounted for 40% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q3 2023 were Bristol-Myers Squibb, AstraZeneca, Novo Nordisk, Novartis, and Sanofi. Together they accounted for a combined share of 40% of all cloud-related new jobs in the pharmaceutical industry.
Bristol-Myers Squibb posted 229 cloud-related new jobs in Q3 2023, AstraZeneca 166 jobs, Novo Nordisk 161 jobs, Novartis 137 jobs, and Sanofi 127 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 36.61% share of total new job postings, Q3 2023
The largest share of cloud-related new job postings in the pharmaceutical industry in Q3 2023 was in the US with 36.61% followed by India (24.62%) and Denmark (4.83%). The share represented by the US was one percentage point lower than the 37.54% share it accounted for in Q2 2023.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q3 2023, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.